Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Keysight Technologies Inc (KEYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Keysight Technologies Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $44.09 (market cap $7.10B), while Keysight Technologies Inc trades at $323.82 (market cap $60.88B). The key difference: Keysight Technologies Inc is far larger — about 8.6× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Keysight Technologies Inc is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Keysight Technologies Inc for 57 Days on average.
| IONS | KEYS | |
|---|---|---|
Market Cap | $7.10B | $60.88B |
Volume | 2,027,457 | 1,470,178 |
Sector | Health | Technology |
52-Week High | $86.50 | $387.90 |
52-Week Low | $42.38 | $162.19 |
Typical Hold Time | 0 Days | 57 Days |
Enterprise Value | $6.66B | $61.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Keysight Technologies (KEYS) trades at $370.22, down 1.98% on the day, with a bullish technical outlook supported by moving averages and strong institutional sentiment. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $3.07 exceeding expectations, and maintains solid profitability with a net income margin of 19.14%. Recent news highlights growth in AI infrastructure and 6G development, positioning KEYS for future expansion amid accelerating demand.
The investment outlook for KEYS is positive, driven by earnings momentum and strategic positioning in high-growth areas like AI and 6G. Key risks include elevated valuation multiples and potential supply constraints, but analyst consensus targets $421.29, suggesting ~14% upside from current levels based on strong fundamentals and institutional support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →
